However, the combined treatment strategy of PD-1 inhibitors and TIGIT inhibitors can increase the number of tumor-infiltrating CTLs, significantly inhibit tumor growth, and prolong the survival of mice [38]. This evidence concerns the gene TIGIT and neoplasm.